The future for limited companies and sole traders working in the UK's pharmaceutical industry is "upbeat" and "optimistic", an industry expert has claimed.
According to law firm Charles Russell, the level of international interest in the industry reveals that the UK is viewed as a "safe harbour" and offers plenty of opportunities for growth.
Tim Jenkins, partner leading the pharmacy transactions team at the law firm, said: "Clearly there will be an ongoing need for pharmacy as a professional service. It's a question of how it will be regulated going forwards, there have obviously been some changes.
"The biggest question is what will happen with control of entry. That's what's in the back of the minds of most operators. I don't see that that uncertainty is having an impact, because uncertainty has always been with us."
As long as the numbers of new businesses arriving on the market continues to increase then the pharmaceutical industry will continue to be buoyant, Mr Jenkins concluded.
Meanwhile, the Council of the Royal Pharmaceutical Society of Great Britain has announced a rise of 2.2 per cent in its fees for 2010.
www.brookson.co.uk
Pharmaceutical Process Equipment
